Investing in biotech: Where are we now and what is the outlook?

Potential implications of US elections on investors

The US Presidential elections have always represented a potentially pivotal moment for the global healthcare sector because of implications on drug pricing – and the recent elections have been no different.

Some investors are understandably concerned that the power to make legislative changes granted by the Democrats' clean sweep − gaining the Presidency, House of Representatives, and the Senate − could have...